Quarterly Activities Report and 4C Quarterly Cash Flow Report

PAT-DX1 GMP specification testing update

Patrys FY24 Annual Report

PAT-DX1 GMP manufacturing run update

Quarterly Activities Report and 4C Quarterly Cash Flow Report – quarter ended 30 June 2024

Update on GMP manufacturing run of PAT-DX1

Quarterly Activities Report and 4C Quarterly Cash Flow Report – quarter ended 31 March 2024

Positive preclinical data for deoxymabs in vasculitis

Potential to use Deoxymabs to treat autoimmune diseases 

Quarterly Activities Report and 4C | 31 December 2023